Sanuwave Health PE Ratio 2012-2025 | SNWV
Current and historical p/e ratio for Sanuwave Health (SNWV) from 2012 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Sanuwave Health PE ratio as of January 09, 2026 is 0.00.
| Sanuwave Health PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2026-01-09 | 30.98 | 0.00 | |
| 2025-09-30 | 37.48 | $-1.30 | 0.00 |
| 2025-06-30 | 32.86 | $-8.25 | 0.00 |
| 2025-03-31 | 35.37 | $-4.56 | 0.00 |
| 2024-12-31 | 23.00 | $-3.90 | 0.00 |
| 2024-09-30 | 11.93 | $8.32 | 1.43 |
| 2024-06-30 | 6.00 | $3.70 | 1.62 |
| 2024-03-31 | 8.08 | $-3.70 | 0.00 |
| 2023-12-31 | 4.88 | $-11.11 | 0.00 |
| 2023-09-30 | 7.91 | $-25.93 | 0.00 |
| 2023-06-30 | 8.51 | $-14.81 | 0.00 |
| 2023-03-31 | 15.75 | $-11.11 | 0.00 |
| 2022-12-31 | 8.55 | $-7.41 | 0.00 |
| 2022-09-30 | 21.56 | $-3.70 | 0.00 |
| 2022-06-30 | 28.50 | $-3.70 | 0.00 |
| 2022-03-31 | 52.50 | $-3.70 | 0.00 |
| 2021-12-31 | 63.75 | 0 | 0.00 |
| 2021-09-30 | 45.00 | 0 | 0.00 |
| 2021-06-30 | 67.20 | $-7.41 | 0.00 |
| 2021-03-31 | 63.75 | $-11.11 | 0.00 |
| 2020-12-31 | 69.38 | $-14.81 | 0.00 |
| 2020-09-30 | 80.63 | $-18.52 | 0.00 |
| 2020-06-30 | 98.44 | $-14.81 | 0.00 |
| 2020-03-31 | 75.00 | $-18.52 | 0.00 |
| 2019-12-31 | 60.00 | $-18.52 | 0.00 |
| 2019-09-30 | 58.09 | $-18.52 | 0.00 |
| 2019-06-30 | 51.93 | $-18.52 | 0.00 |
| 2019-03-31 | 75.94 | $-18.52 | 0.00 |
| 2018-12-31 | 86.25 | $-29.63 | 0.00 |
| 2018-09-30 | 73.13 | $-33.33 | 0.00 |
| 2018-06-30 | 163.80 | $-33.33 | 0.00 |
| 2018-03-31 | 195.38 | $-29.63 | 0.00 |
| 2017-12-31 | 90.75 | $-14.81 | 0.00 |
| 2017-09-30 | 63.75 | $-14.81 | 0.00 |
| 2017-06-30 | 42.19 | $-14.81 | 0.00 |
| 2017-03-31 | 48.75 | $-14.81 | 0.00 |
| 2016-12-31 | 65.59 | $-22.22 | 0.00 |
| 2016-09-30 | 56.25 | $-22.22 | 0.00 |
| 2016-06-30 | 15.38 | $-25.93 | 0.00 |
| 2016-03-31 | 19.54 | $-29.63 | 0.00 |
| 2015-12-31 | 24.38 | $-29.63 | 0.00 |
| 2015-09-30 | 42.75 | $-22.22 | 0.00 |
| 2015-06-30 | 71.25 | $-25.93 | 0.00 |
| 2015-03-31 | 48.75 | $-29.63 | 0.00 |
| 2014-12-31 | 65.63 | $-44.44 | 0.00 |
| 2014-09-30 | 78.75 | $-44.44 | 0.00 |
| 2014-06-30 | 198.75 | $-85.19 | 0.00 |
| 2014-03-31 | 254.63 | $-88.89 | 0.00 |
| 2013-12-31 | 210.00 | $-159.26 | 0.00 |
| 2013-09-30 | 255.00 | $-185.19 | 0.00 |
| 2013-06-30 | 251.25 | $-159.26 | 0.00 |
| 2013-03-31 | 341.25 | $-170.37 | 0.00 |
| 2012-12-31 | 60.00 | $-111.11 | 0.00 |
| 2012-09-30 | 110.63 | $-125.93 | 0.00 |
| 2012-06-30 | 112.50 | $-137.04 | 0.00 |
| 2012-03-31 | 150.00 | $-174.07 | 0.00 |
| 2011-12-31 | 97.50 | $-192.59 | 0.00 |
| 2011-09-30 | 1012.50 | $-329.63 | 0.00 |
| 2011-06-30 | 1248.75 | $-292.59 | 0.00 |
| 2011-03-31 | 2062.50 | $-311.11 | 0.00 |
| 2010-12-31 | 1601.25 | $-259.26 | 0.00 |
| 2010-09-30 | 937.50 | $-81.48 | 0.00 |
| 2010-06-30 | 1537.50 | $-81.48 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.266B | $0.033B |
| SANUWAVE Health, Inc. is engaged in the development and commercialization of non-invasive, biological response-activating devices for the repair and regeneration of tissue, musculoskeletal and vascular structures. The Company's product candidates include its proprietary PACE technology applicable in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions; and dermaPACE for treatment of the skin and subcutaneous soft tissue. The Company's products help in activating biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. SANUWAVE Health, Inc. is based in Alpharetta, USA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $218.959B | 25.23 |
| EssilorLuxottica (ESLOY) | France | $150.458B | 0.00 |
| Boston Scientific (BSX) | United States | $144.746B | 33.10 |
| Stryker (SYK) | United States | $140.556B | 27.91 |
| Medtronic (MDT) | Ireland | $125.035B | 17.32 |
| Medline (MDLN) | United States | $53.232B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.704B | 0.00 |
| Agilent Technologies (A) | United States | $42.105B | 26.62 |
| GE HealthCare Technologies (GEHC) | United States | $39.758B | 19.01 |
| ResMed (RMD) | United States | $36.846B | 25.50 |
| Koninklijke Philips (PHG) | Netherlands | $28.483B | 18.60 |
| Terumo (TRUMY) | Japan | $21.735B | 24.47 |
| Insulet (PODD) | United States | $20.333B | 63.11 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.401B | 11.48 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.263B | 0.00 |
| Baxter (BAX) | United States | $10.831B | 8.74 |
| Sunny Optical Technology (SNPTF) | China | $9.589B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.735B | 31.41 |
| Demant (WILYY) | Denmark | $7.372B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.480B | 13.65 |
| BillionToOne (BLLN) | United States | $3.933B | 0.00 |
| Envista Holdings (NVST) | United States | $3.885B | 22.29 |
| Haemonetics (HAE) | United States | $3.840B | 17.09 |
| ICU Medical (ICUI) | United States | $3.777B | 23.98 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.099B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.086B | 14.07 |
| QuidelOrtho (QDEL) | United States | $2.286B | 14.69 |
| Neogen (NEOG) | United States | $2.093B | 45.81 |
| Perrigo (PRGO) | Ireland | $2.075B | 5.20 |
| AtriCure (ATRC) | United States | $2.061B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.928B | 38.81 |
| Curaleaf Holdings (CURLF) | Canada | $1.716B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.680B | 73.64 |
| Phibro Animal Health (PAHC) | United States | $1.599B | 15.97 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.577B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.425B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.421B | 20.57 |
| BioLife Solutions (BLFS) | United States | $1.197B | 355.14 |
| Capricor Therapeutics (CAPR) | United States | $1.090B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.031B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.005B | 0.00 |
| InMode (INMD) | Israel | $0.913B | 10.31 |
| Omeros (OMER) | United States | $0.886B | 0.00 |
| CeriBell (CBLL) | United States | $0.865B | 0.00 |
| Valneva SE (VALN) | France | $0.850B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.563B | 15.26 |
| Verano Holdings (VRNO) | United States | $0.461B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.453B | 0.00 |
| Brainsway (BWAY) | Israel | $0.453B | 77.03 |
| Cresco Labs (CRLBF) | United States | $0.443B | 0.00 |
| SNDL (SNDL) | Canada | $0.436B | 0.00 |
| Cerus (CERS) | United States | $0.396B | 0.00 |
| Quanterix (QTRX) | United States | $0.376B | 0.00 |
| Evolus (EOLS) | United States | $0.366B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.290B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.275B | 21.94 |
| TerrAscend (TSNDF) | Canada | $0.242B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.240B | 141.00 |
| High Tide (HITI) | Canada | $0.234B | 0.00 |
| Organigram Global (OGI) | Canada | $0.232B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.217B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Vireo Growth (VREOF) | United States | $0.208B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.192B | 16.92 |
| Accendra Health (ACH) | United States | $0.190B | 1.91 |
| OraSure Technologies (OSUR) | United States | $0.189B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.154B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.145B | 0.00 |
| Exagen (XGN) | United States | $0.144B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.137B | 0.00 |
| Apyx Medical (APYX) | United States | $0.133B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.118B | 0.00 |
| Biote (BTMD) | United States | $0.118B | 5.16 |
| MacroGenics (MGNX) | United States | $0.116B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.71 |
| ImmuCell (ICCC) | United States | $0.059B | 24.98 |
| Sharps Technology (STSS) | United States | $0.055B | 0.00 |
| Nephros (NEPH) | United States | $0.051B | 37.00 |
| Cytosorbents (CTSO) | United States | $0.042B | 0.00 |
| Jin Medical (ZJYL) | China | $0.039B | 0.00 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.029B | 14.53 |
| Allurion Technologies (ALUR) | United States | $0.016B | 0.00 |
| Bonk (BNKK) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| Flora Growth (FLGC) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |